https://insideevs.com/news/595676/rivian-canada-deliveries-delayed-h2-2023/amp/
Merus N.V. Announces Proposed Public Offering Of Common Shares; No Size Or Amount Disclosed
Merus N.V. (NASDAQ:MRUS) ("Merus", the "Company," "we" and "our"), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced the